Item request has been placed!

Item request cannot be made.

Processing Request

Randomised phase II BGOG/ENGOT-CX1 study of Paclitaxel-Carboplatin with or without Nintedanib in first-line recurrent or advanced cervical cancer

Item request has been placed!

Item request cannot be made.

Processing Request

Read More Add to Saved list

Author(s): Vergote, IB; Van Nieuwenhuysen, E; Casado, A; Laenen, A; Lorusso, D; Braicu, I; Guerra-Alia, E; Zola, P; Wimberger, P; Debruyne, P; Falco, E; Ferrero, A; Muallem, MZ; Kerger, J; Garcia Martinez, E; Pignata, S; Sehouli, J; Van Gorp, T; GENNIGENS, Christine; Rubio Pérez, MJ
Source:
Int J Gynecol Cancer: first published as 10.1136/ijgc-2021-ESGO.16, 12 octobre 2021
Subject Terms:
Paclitaxel-Carboplatin; Nintedanib; cervical cancer; Human health sciences; Oncology; Sciences de la santé humaine; Oncologie
Document Type:
conference paper not in proceedings
http://purl.org/coar/resource_type/c_18cp
conferencePaper
Language:
English
Online Access:
https://orbi.uliege.be/handle/2268/264510

Additional Information
- Publication Date:
  2021
- Rights:
  open access
  http://purl.org/coar/access_right/c_abf2
  info:eu-repo/semantics/openAccess
- Accession Number:
  edsorb.264510

Comments

No Comments.